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KESAN GALAKTOSA DAN FRUKTOSA KE ATAS EKSPRESI ENZIM 
ISOSITRAT LIASE (ICL1) DALAM Candida albicans 
 
ABSTRAK 
 
 
 
 
Sifat kepatogenan dalam C. albicans bergantung kepada atribut kecergasan dan 
juga faktor-faktor virulen yang lain. Ini termasuk sifat kental terhadap tindak balas 
tekanan dan penyesuaian metabolik. C. albicans boleh menduduki kebanyakkan 
persekitaran dalam ruang badan manusia yang mengandungi kepelbagaian sumber 
karbon yang berbeza. Asimilasi sumber karbon adalah penting untuk pertumbuhan dan 
juga untuk meneruskan jangkitan. Tesis ini mengkaji kesan galaktosa atau fruktosa 
terhadap  asimilasi  sumber  karbon  sekunder  seperti  laktat  oleh  C.  albicans.  Gen 
C. albicans Isositrat liase (CaICL1) ditindas oleh penambahan 2% galaktosa atau 
fruktosa kepada sel-sel yang sedang membiak pada laktat. Gen CaICL1 yang mengekod 
kitaran glioksilat enzim Icl1 diperlukan untuk pertumbuhan dalam mengunakan sumber 
karbon sekunder seperti laktat. Enzim CaIcl1 didapati stabil dalam galaktosa tetapi tidak 
stabil dalam fruktosa. Sebaliknya, kedua-dua galaktosa dan fruktosa mendegradasikan 
protein S. cerevisiae Icl1 (ScIcl1). Saringan laman pengubikuitinan oleh 
http://www.ubpred.org/ menunjukkan C. albicans tidak mempunyai tapak 
pengubikuitinan dalam enzim glukoneogenik dan kitaran glioksilat berbanding dengan 
S. cerevisiae. Penambahan tapak pengubikuitinan daripada ScIcl1 kepada CaIcl1 
memberi kesan kepada degradasi protein Icl1 sebagai tindakbalas kepada galaktosa 
dalam sel C. albicans melalui satu proses yang bergantung pada ubikuitin. CaIcl selepas 
14  
penambahan tapak pengubikuitinan menunjukan peningkatan kepada kelajuan degradasi 
protein apabila terdedah kepada fruktosa. Dengan itu C. albicans telah kehilangan radas 
molekul yang mencetuskan ketidakstabilan protein sasaran sebagai tindak balas kepada 
galaktosa dan kesannya boleh mengasimilasikan sumber karbon alternatif dan galaktosa 
dalam masa yang serentak. Ini merupakan faktor dominan yang menyumbang kepada 
fleksibiliti metabolik seterusnya kevirulenan dalam C. albicans. 
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EFFECTS OF GALACTOSE AND FRUCTOSE ON THE EXPRESSION OF 
ISOCITRATE LYASE (ICL1) ENZYME IN Candida albicans 
 
ABSTRACT 
 
 
 
 
The virulence of C. albicans is dependent upon fitness attributes as well as 
virulence factors. These attributes include robust stress responses and metabolic 
flexibility. C. albicans can occupy a variety niches in human, many of which contain a 
range of different carbon sources. The assimilation of these carbon sources is important 
for growth and essential for establishment of infections by C. albicans. This thesis 
examines the impact of galactose or fructose upon the assimilation of secondary carbon 
sources such as lactate by C. albicans Isocitrate lyase gene (CaICL1) is repressed upon 
addition of 2% galactose or fructose to lactate- grown cells. The CaICL1 gene, which 
encode the glyoxylate cycles enzymes isocitrate lyase are required for growth on non- 
fermentable carbon sources such as lactate. However the enzyme CaIcl1 was not 
destabilized by galactose, but was degraded in response to fructose. In contrast, 
S. cerevisiae Icl1 (ScIcl1) was rapidly degraded in response to either galactose or 
fructose.  Screening  of  ubiquitination  site by http://www.ubpred.org/  showed  that 
C. albicans lacks ubiquitination site in gluconeogenic and glyoxylate cycles enzymes as 
compare to S. cerevisiae, Addition of a putative S. cerevisiae ubiquitination site at 
carboxy terminus of CaIcl1 led to galactose- accelerated degradation of this protein in 
C. albicans cell via a ubiquitin-dependent process. In the other hand, CaIcl prior to 
addition of ubiquitination site was degraded upon exposure to fructose; addition of 
16  
S. cerevisiae ubiquitination site to CaIcl1 further increased the rate of protein 
degradation. Thereby in conclusion, C. albicans has lost the molecular apparatus that 
triggers the destabilization of target proteins in response to galactose and can 
simultaneously assimilate alternative carbon sources and galactose, a dominant factor 
that contribute to metabolic flexibility subsequently virulency of C. albicans. 
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CHAPTER 1: INTRODUCTION 
 
 
 
 
1.1 Candida spp. and Candidiasis 
 
 
 
 
Approximately 200 species of fungi were recognized as human/animal pathogen 
(Kwon-Chung & Bennett, 1992; Rippon, 1988). Fungal diseases (mycosis) are often 
caused by around 50 of these species. Yeast such as Candida species, Cryptococcus (Cr.) 
neoformans, and Cr. gattii are the well known for causing diseases (Kurtzman et al., 
2011). Candida spp. are normally harmless and exist in a symbiotic mutualistic 
relationship with humans and inhabited skin, mucocutaneous tissues, and 
gastrointestinal tract (Kurtzman et al., 2011). However given opportunity, they can take 
advantage of local and systemic weakness in host immune system, such as patients 
undergoing cancer chemotherapy treatment, or infected with HIV or in neonates or when 
environmental niche become available (for example, after antibiotic treatment), to cause 
superficial infections, such as vaginitis and oral thrush, and blood stream infection 
(Pappas, Silveira, et al., 2009; Berman & Sudbery, 2002; Kao et al., 1999). Such 
infections, termed candidiasis, are the fourth most common hospital-acquired infection 
in USA (8 out of 100,000 per annum), with 40% mortality rate and approximately 
10,000 death per year (Edmond et al., 1999; Kao et al., 1999). Out of all the disease 
causing Candida spp., C. albicans is accounted for 40-60% of the cases (Bassetti et al., 
2006). 
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1.1.1 Asexual and Parasexual Reproduction in C. albicans 
 
 
 
 
Candida albicans are eukaryotic diploid (2N) sexual yeasts (Kurtzman & Fell, 1998) 
and can divide asexually or can undergo parasexual reproduction (Ene & Bennett, 2014). 
C. albicans MTL (mating-type-like) loci is homologous to the Saccharomyces cerevisiae 
MAT (mating type) loci (Hull & Johnson, 1999). Members of the genus Candida are 
very incongruous and can grow in at least 3 different structures; yeast, pseudohyphae 
and hyphae, such as C. albicans and  C. dubliniensis (Sudbery et al., 2004; R.A. 
Calderone, 2002). Other morphology occur during colony switching, white domed 
colonies switch reversibly to opaque flat colonies (white-opaque switching system) 
(Slutsky et al., 1987). To enable Candida cells to mate, mating type-like locus a (MTLa) 
and MTLα cells must switch from white to opaque (Butler et al., 2009). Opaque cells 
secreted pheromones to form conjugation tubes, and subsequently, tetraploid (4N) cells 
through nuclear fusion. In order to return to the diploid state, mating products can be 
induced to undergo concerted chromosome loss (Forche et al., 2008; Bennett & 
Johnson, 2003). 
 
 
 
1.1.2 Clinical Manifestation 
 
 
 
 
Mycoses are generally categorized into three groups: systemic mycose, dermotophytose 
and superficial mycoses. Although these categories are useful, some mycoses overlap 
and fall into all three categories, e.g. candidiasis (Bulmer, 1995). 
 
 
 
Systemic candidiasis or invasive candidiasis occurs when Candida invade and spread 
via the bloodstream to multiple organs (Parker et al., 1976). Candida contamination of 
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indwelling intravascular catheters may result in Candidemia (Karlowsky et al., 1997). 
Candidiasis can also occurs after surgical procedures, or injuries to the skin, respiratory 
tract, or gastrointestinal (Wenzel, 1995) and lengthy therapy with wide range of 
antibiotics or corticosteroids (Pfaller, 1996). Initially, the patients have irregular, lengthy, 
or continuous fever and are unresponsive to antimicrobial chemotherapy. Many organ 
ailment may rise from haematological dissemination, some of these ailment may resolve 
impromptu under antimycotic therapy; others may result in permanent defects such as 
loss of vision after endophthalmitis. Substantial Candida colonization of the 
gastrointestinal, respiratory, or urinary tract of a post-surgical or impaired immune 
system patients, may cause invasion of mucosa or serosa subsequently producing 
infections such as, cystitis, esophagitis, peritonitis or pyelonephritis via penetration into 
adjacent deeper tissue. In small children, blockage or unsuccessful discharge in the 
gastrointestinal or urinary tract be capable of leading to gathering of Candida biomass 
and subsequently forming fungus balls in the the stomach, renal pelvis, or other natural 
body cavities. There is normally no invasion of the deeper tissue or mucosa. Removal of 
the fungal mass through surgical drainage should resolves the problem (Jucker, 2003). 
 
 
 
1.2 Antifungal Agents 
 
 
 
 
Candida spp. produce a broad spectrum of infections, from non-lethal mucocutaneous 
disease to invasive process that involve wide range of organs. In order to counter such a 
wide range of infections, a variety of diagnostic and treatments were required. 
According to the latest guidelines of the Infectious Diseases Society of America (IDSA), 
the choice of anti-fungal treatment should be based on the clinical condition of the 
patient, information on the species and antifungal susceptibility of the fungus isolated 
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from the patient, drug toxicity level, signs of organ failure and secondary affected drug 
clearance, and the condition of patient before exposure to anti-fungal drugs (De Rosa et 
al., 2009; Pappas, Kauffman, et al., 2009). The major groups of antifungals are 
polyenes, azoles, echinocandins, allylamine and morpholine, and antimetabolite, such as 
5-fluorocytosine. These groups are distinguished primarily by the chemical structure and 
mechanism of action. 
 
 
 
Polyene antifungal agents, such as Amphotericin B, pimaricin and nystatin interact with 
cell membrane components, such as ergosterol in fungi and cholesterol in humans, to 
form channels, thereby perturbing membrane function causing small leakage of cellular 
contents from the inside of the fungal cell to the outside (F. C. Odds et al., 2003). 
Amphotericin B has a relatively broad spectrum of action against dimorphic fungi, 
molds (e.g. Aspergillus spp.), and yeasts (e.g. Candida spp., Cryptococcus neoformans). 
Amphotericin B is the only fungal polyene that can be administered systemically to treat 
visceral infection. The only disadvantages from the use of Amphotericin B are its poor 
aqueous solubility and toxicity to mammalian cells (F. C. Odds et al., 2003). 
 
 
 
Azole antifungal agents inhibit cytochrome P-450-dependent enzyme lanosterol 
demethylase (also known as 14α-sterol demethylase), which involved in the biosynthesis 
of ergosterol. Ergosterol is required for construction of fungal cell membrane structure 
and function (Neely & Ghannoum, 2000; Georgopapadakou & Walsh, 1996). As a 
result, ergosterol in the cell membrane is depleted; membrane functions and structure are 
altered, thus inhibiting the fungal growth (Pfaller, 2012). 
 
 
 
Echinocandins (anidulafungin, caspofungin and micafungin) are fungal secondary 
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metabolites, they have a cyclic hexapeptide core with a lipid side-chain responsible for 
anti-fungal activity by targeting and inhibits the synthesis of β-1,3-D glucan (F. C. Odds 
et al., 2003). β-1,3-D glucan is essential to the function and structure of the fungal cell 
wall. Echinocandins causes the formation of a faulty cell wall and leads to instability 
subsequently cell rupture in yeasts, and abnormal growth of hyphae in molds. 
Echinocandins have no effect against, Fusarium, Cryptococcus, Scedosporium and 
Trichosporon species or zygomycetes but are are highly effective against Candida and 
Aspergillus species (Espinel-Ingroff, 2003). 
 
 
 
Allylamine, such as naftifine and terbinafine inhibit squalene epoxidase in ergosterol 
biosynthesis pathway. Similarly amorolfine, the morpholine drug inhibits downstream of 
the same pathway (Ryder & Mieth, 1992). The allylamine antimycotic terbinafine is 
efficient in vitro against a variety of disease causing fungi. It can be administered orally 
and can be applied directly to body surface in the therapy of fungal infections of the hair, 
skin and nails (Balfour & Faulds, 1992). Clinical study have shown topical and oral 
terbinafine to be effective in Candida nail infections and skin candidiasis (Ryder et al., 
1998). 
 
 
 
 
Antimetabolite fungal agents, 5-Fluorocytosine (5-FC) functions by preventing fungi’s 
DNA and RNA synthesis, 5-FC can be used in combination with Amphotericin B to treat 
serious systemic infection, such as candidosis, cryptococcosis, aspergillosis and 
chromoblastomycosis. 5-FC is rarely used alone (monotherapy) because of frequent 
development of resistance. However usage of     5-FC has severe side effects such as 
hepatoxicity and bone-marrow depression (Vermes et al., 2000). 
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1.3 Antifungal Resistance 
 
 
 
 
Clinical and Laboratory Standards Institute (CLSI) in the United States has issued 
standardized methods to test in vitro susceptibility of antifungal resistance. Similar 
testing protocol was issued by the European Committee on Antimicrobial Susceptibility 
Testing (EUCAST) in Europe (Cuenca-Estrella et al., 2010). A fungus strain is classified 
as resistance when the fungus are no longer susceptible to an antifungal agent or when 
the Minimal Inhibitory Concentration (MIC) of the drug exceeds the susceptibility 
breakpoint for the organism (Kanafani & Perfect, 2008). Antifungal resistance can be 
categorized into microbial or clinical resistance, or mixed of both category (Turnidge & 
Paterson, 2007). Clinical resistance occurs when the administration of an antifungal 
drugs fails to treat a fungal infection (Kanafani & Perfect, 2008). Resistance can be 
intrinsic (primary) or acquired (secondary). Intrinsic resistance belongs naturally to the 
fungi. Fungi with intrinsic resistance are resistance to the antifungal agent even before 
coming in contact with the drug. Example includes resistance of C. krusei to 
fluconazole. Fluconazole resistance among C. albicans is an acquired resistance due to 
the exposure of susceptible strain to the antifungal agent (Marichal et al., 1999). 
Resistance also occurs when environmental factors causes the replacement of the 
susceptible species with a resistant one (Pfaller, 2012). MIC values do not always 
correspond to antifungal therapy and MIC levels are not always reliable (Rex & Pfaller, 
2002). The difference between in vivo and in vitro data followed a pattern of “90-60” 
rule, infection due to non-resistant isolate react to therapy ~90% of the time, whereas 
infections due to resistant isolate react ~60% of the time (Rex & Pfaller, 2002). 
 
 
 
Better  understanding  for  mechanisms  of  action  of  different  antifungal  agents  is 
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necessary to understand the mechanism of resistance. Mechanisms of resistance in fungi, 
are caused by mutation in gene encoding target proteins, development of active efflux 
pumps to reduce concentration of the drug, development of detour pathways and up- 
regulation of target enzyme. For example, depletion of ergosterol from the fungal 
membrane is consequence of exposure to azole anti-fungal agent and leads to 
accumulation of toxic product 14α-methyl-3,6-diol, therefore resulted in redundant 
growth. erg3/erg3 mutant inhibits formation of 14α-methyl-3,6-diol (Spampinato & 
Leonardi, 2013; Pfaller, 2012; Peman et al., 2009; Kanafani & Perfect, 2008). 
 
 
 
1.4 Virulence and Pathogenicity in C. albicans 
 
 
 
 
Pathogen is microorganism that has gained ability to cause infection of a host and yield 
disease. It depends on the expression of virulence factors on both sides of host and 
pathogen. A fungus pathogen can acclimate to the tissue environment and confront the 
lytic activity of the host’s defense. Virulence is the ability of a pathogen to multiply, 
cause harm to its host and produce disease in patient (Casadevall, 2007). Virulence is 
attributed to several factors including adherence, secreted degradative enzymes, 
morphology switching, biofilms and quorum sensing (Fig. 1.1) (Lim et al., 2012). 
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Figure 1.1 Virulence factors of C. albicans. Factors and genes involved in virulence of 
C. albicans. Genes discussed are listed under each category of virulence factors: 
A) Genes associated with adhesion of C. albicans to host cells 
B)  Genes associated with formation of hyphal formation of C. albicans 
C) Genes associated morphological transition and phenotypic switching 
D) Genes associated with secretion of protease by hyphae 
E)  Genes associated with biofilm formation 
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1.4.1 Adhesion 
 
 
 
 
Adherence of C. albicans to host cells is important for commencing and maintaining a 
commensal relationship (Gaur et al., 1999), as well as for establishment of disease 
through the settlement of host niches (Chaffin et al., 1998). It is a complex mechanism 
utilizing several types of adhesins, including agglutinin- like sequence (ALS) and hyphal 
wall protein (Hwp1) (Mayer et al., 2013; Yang, 2003). Glycosylphosphatidylinositol 
(GPI)- linked cell surface glycoproteins (Als1-7 and Als9) was encoded by ALS gene , 
these proteins are homologous to α-agglutinin, required for cell-cell recognition during 
mating in  S. cerevisiae (R. A. Calderone & Fonzi, 2001). Als1, Als3 and Als5 (Ala1) 
have an attachment function to human buccal epithelial cells (HBEC) and fibronectin, 
collagen, laminin and endothelial cells (Hoyer, 2001; Hawser & Douglas, 1994). Als4p 
binds to endothelial cells, Als5 is for cell aggregation, Als6 bind to collagen and Als9 
binds to laminin. Als1 is vital for the attachment of the microorganism to the oral 
mucosa during the initial phase of the infection (Kamai et al., 2002). Hypha-associated 
adhesion Als3 is vital for adhesion (Murciano et al., 2012; Phan et al., 2007). ALS3 gene 
was highly expressed during infection of in vivo vaginitis and during infection of oral 
epithelial cells in vitro (Naglik et al., 2011; Wachtler et al., 2011; Cheng et al., 2005). 
HWP1 encodes an outer surface mannoprotein on the hyphal wall (transglutaminase 
substrate, TGase) and form covalent binding with HBEC (Staab et al., 1996). An 
hwp1/hwp1 mutant strain was greatly defective in the ability to adhere to HBEC and 
display attenuated virulence in a murine model of systemic candidiasis (Staab et al., 
1999; Chaffin et al., 1998). 
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1.4.2 Secreted Degradative Enzymes 
 
 
 
 
Following attachment to host cell surfaces and hyphae growth, proteinases was secreted 
by pathogen’s hyphae in order to degrade the tissue lining and acquire nutrition at the 
infection site (Wachtler et al., 2012; Naglik et al., 2003). Secreted aspartyl proteinases 
(SAP) from Candida dissolved many proteins at laceration sites, such as collagen, 
haemoglobin, keratin, albumin, Immunoglobulin A, fibronectin, cystatin A, salivary 
lactoferin, interleukin1β, mucin, and laminin (Hube et al., 1998). SAP comprises of ten 
members, Sap1-10. Sap9 and Sap10 remain constrained to the cell-surface and Sap1-8 
are released to the surrounding medium (Taylor et al., 2005; Naglik et al., 2003). 
Expression of Saps 1, 2 and 3 by the yeast phase are required for virulence in a murine 
model of systemic infection, and for invasion of reconstituted human epithelium (RHE) 
in vitro (Schaller et al., 1999; Hube et al., 1997). Saps 4, 5 and 6 are expressed in the 
passage from yeast to hyphae phase at neutral pH. Sap7 was never detected in vitro 
whereas, Saps 9 and 10 manifest in both forms (yeast and hyphae) (Albrecht et al., 
2006). 
 
 
 
 
Enzymes such as phospholipases (PL) digest ester linkages of glycophospholipids and 
allow Candida cells to invade tissue. There are four different classes of phospholipases 
(PLA, PLB, PLC and PLD); out of these four classes only the five member of PLB 
(PLB1-5) are situated outside a cell and has both fatty acid release (hydrolase) and 
lysophospholipase- transacylase activities (Mavor et al., 2005; Niewerth & Korting, 
2001). There is higher level of phospholipases in C. albicans strains isolated from blood 
than commensal strains (Ibrahim et al., 1995); cells producing less phospholipase are 
less likely to cause disease than strains producing high phospholipase in mouse model 
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(Theiss et al., 2006; Ghannoum, 2000). Therefore high level of phospholipase activity is 
discovered at where the hyphae were in direct contact with the object (Pugh & Cawson, 
1977). 
 
 
 
 
1.4.3 Morphological Transition and Phenotypic Switching 
 
 
 
 
Morphological transition in C. albicans is the ability to switch between the unicellular 
yeast form, such as blastospores, and the filamentous form, such as pseudohyphae or 
hyphae. Out of all the Candida spp., only C. dubliniensis and C. albicans can undergo 
morphogenesis. Morphological conversion from yeast cells (round/oxoid in shape and 
readily separate) to pseudohyphae (extended ellipsoidal cells with constraints at the 
septa) or parallel-walled true hyphae is facilitated by ~pH 7, nutrients, temperature of 
37-40ºC, approximately 5.5% of CO2 concentration and presence of biotin, amino acid, 
serum and N-acetyl-D-glucosamine. Reverse conversion from hyphae to yeast form 
occurs when cells are grown in higher concentration of glucose, absence of serum, 
acidic pH, and lower temperature (Eckert et al., 2007; Corner & Magee, 1997). In 
C. albicans, this conversion is controlled by 2 regulatory proteins, Cph1 and Efg1, 
which are homolog to S. cerevisiae, Ste12 and Phd1 respectively (Lewis, Lo, et al., 
2002). C. albicans mutant strains (cph1 and efg1) have morphogenesis defects, such as 
defective in filamentous growth and are unable to form filaments when it is exposed to 
many stimuli including macrophage and serum. Candida mutant strains, cph1/cph1 and 
efg1/efg1 are avirulent in mouse model (Lewis, Lo, et al., 2002). This transition (yeast to 
psedohyphae or hyphae and vice versa) is termed dimorphism and it is required for 
pathogenesis, as yeast forms are suited for dissemination in tissue and hyphae forms are 
required for invasion and tissue damage. The yeast cell that develops into hyphae is able 
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to kill macrophages (upon phagocytozed by macrophages) by secreting hyphae 
associated proteinases; these factors also help hyphae cells in resist to neutrophils. 
Hyphae cells also induce transmigration through endothelial cells from bloodstream 
(Hube, 2004; Gow et al., 2002; Molero et al., 1998). 
 
 
 
The colonies of C. albicans show distinct morphological form, including white round- 
oxoid cells, gray colonies with elongated shaped cells (opaque), hat, irregular wrinkle, 
strippled, fuzzy, star, and rough at high frequency (10
-4 
to 10
-1
) (Sudbery et al., 2004). It 
is not known what causes phenotypic switching and how switching affect virulence of 
C. albicans. Switching happen more frequently in cells isolated directly from vaginitis 
or systemically infected patients (Jones et al., 1994; Soll, 1988). White-phase cells have 
lower frequency for mating and lower capability to colonize skin in a cutaneous model 
than opaque-phase cells. White-phase cells are more virulent in systemic infection while 
opaque-phase cells in cutaneous infection of murine model (Kvaal et al., 1999). 
Expression of gene SAP1 and SAP3 only occur in opaque cells, while expression of 
 
SAP2, WHI1, and EFG1 occur specifically in white-phase cells (Miller & Johnson, 
 
2002). Morphology transition is important for C. albicans in its adaptation or infection 
of the fungus to specific organs, such as skin, kidney and endothelial lining in blood 
vessels. 
 
 
 
1.4.4 Biofilms 
 
 
 
 
A vital virulence factor of C. albicans is its ability to forms biofilms. Formation of 
biofilms starts with adherence of C. albicans cells to non biotic material, such as 
catheters and dentures, or to biotic surfaces, such as mucosal cell surfaces. Biofilms 
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results in an increase in candidemia and antifungal resistance (Chandra, Kuhn, et al., 
 
2001; Hawser & Douglas, 1994). Devices like catheters and dentures provide a platform 
for Candida cells to form biofilms. Formations of biofilms proceeds in three 
development phases: early (attachment of Candida cells to abiotic or biotic platform and 
expansion of these cells), intermediate (accumulation of extracellular matrix material 
(ECM) and development of hyphae cells on upper part of the biofilm), and mature 
(biofilm complex distribute Candida cells to the surrounding). Mature biofilms are more 
resistant to the exposure of antifungal agents and host immune factors in comparison to 
planktonic cells (Finkel & Mitchell, 2011). C. albicans biofilm is resistant to variety of 
azoles, including voriconazole (Lewis, Kontoyiannis, et al., 2002), miconazole (Lamfon 
et al., 2004), ketoconazole, itraconazole and fluconazole, (Hawser & Douglas, 1995), 
polyenes nystatin and Amphotericin B, (Chandra, Kuhn, et al., 2001; Chandra, 
Mukherjee, et al., 2001) and flucytosine (Hawser & Douglas, 1995). Azole resistant in 
C. albicans biofilms may be attributed to the high levels expression of the drug efflux 
determinants MDR1, major facilitator superfamily transporter, and the ATP-binding 
cassette transporters CDR1 and CDR2 (Lupetti et al., 2002). 
 
 
 
One important component of C. albicans biofilms is ECM, which is proposed to provide 
a structural scaffold and protection for biofilm cells (Taff et al., 2012). ECM is mainly 
made from β-1,3 glucan (encoded by SKN1 and KRE1). Higher Amphotericin B 
resistance corresponded to upregulation of KRE1 transcript in yeast (Breinig et al., 
2004). β-1,3 glucan in ECM also protect C. albicans from neutrophils attacks and do not 
trigger production of reactive oxygen species (ROS) (Z. Xie et al., 2012). 
14  
1.5 Transmigration 
 
 
 
 
Adhesion of C. albicans to the endothelium of the blood vessels triggers the invasion or 
transmigration of C. albicans across the endothelium. Several mechanisms were 
proposed for Candida migrates across the endothelium, Two of the mechanisms are 
induced endocytosis and active penetration (Naglik et al., 2011; Zhu & Filler, 2010). For 
induced endocytosis, adherent organism was endocytosed by endothelium allowing 
adherent cell to cross abluminal surface of the endothelium. On the cell surface of 
endothelium, the fungus synthesized specialized proteins that binds to ligand E-cadherin 
on host epithelium cells and N-cadherin on endothelium cells via the Candida protein 
Als3, thereby triggering endocytosis of the C. albicans across the endothelial barrier 
(Phan et al., 2007; Phan et al., 2005). So far two genes associated to invasion have been 
identified, SSA1 and ALS3 which functions as both adhesin and invasin (Sun et al., 
2010; Phan et al., 2007). SSA1 induced the expression of heat shock protein 70 (HSP70) 
family on the cell surface and deletion of both SSA1 and ALS3 genes resulted in reduced 
epithelial adherence and invasion. Similarly mutant strains show less frequency in 
causing oropharyngeal candidiasis in a mouse model (Naglik et al., 2011; Sun et al., 
2010). Als1 and Ssa1 bind to host E-cadherin subsequently induces tyrosine 
phosphorylation of unknown intracellular endothelial cell proteins (Belanger et al., 
2002). These binding produce pseudopods through microfilament rearrangement 
subsequently trigger endocytosis of adherent C. albicans hyphae cells (Phan et al., 2007; 
Filler et al., 1995). Active penetration of C. albicans into endothelial cells requires the 
elongation of hyphae to penetrate through the endothelial cells and likely kill the cells 
along the process (Wachtler et al., 2011; Dalle et al., 2010). It is not well understood 
what exactly facilitates active penetration of host cells. However, it is presumed that 
15  
factors such as physical forces and fungal adhesion are crucial (Wachtler et al., 2011). It 
is not only the hyphal form of C. albicans that can undergoes endocytosis; unchanged 
strains can also undergo endocytosis to a certain degree causing minimal damage to the 
endothelial cells (Klotz et al., 1983). Induced endocytosis is a passive process and does 
not required living fungal cells as even dead hyphae cells are endocytosed (Dalle et al., 
2010; Park et al., 2005). 
 
 
 
 
1.6 Fitness Attribute 
 
 
 
 
Adaptation to the environment is vital to pathogens such as C. albicans to allow them to 
grow and expand in wide range environments, such as within their mammalian host and 
cause infection. C. albicans can grows in variety niches in human and metabolize 
different carbon sources that are present in the host. Environment adaptation involves 
both metabolic and stress adaptation. Stress responses can be initiated in response to a 
wide-range of environmental stimulus including heat-shocks, osmotic and cationic, 
oxidation, nitrosative and cell wall stresses (A. J. Brown et al., 2014). Regulation of 
C. albicans metabolism and activation of specific stress responses are initiated upon 
contact with host. Metabolic flexibility and stress response represent crucial fitness 
attributes that have evolves alongside with virulence attributes in C. albicans and is 
important for cells viability (Barelle et al., 2006; Lorenz & Fink, 2001). 
 
 
 
1.6.1 Heat-shocks 
 
 
 
 
Numerous studies have shown that the pathogenicity of C. albicans is influenced by heat 
shock response. Stress response by heat shock proteins (Hsp70 and Hsp90) mark 
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damaged or aggregated proteins for degradation, or encourage the folding of target 
proteins (Feder & Hofmann, 1999; Parsell et al., 1993). The response in C. albicans is 
regulated by the heat shock transcription factor Hsf1 (Nicholls et al., 2009). Hsf1 is 
essential for cells viability in yeast. C. albicans exposure to acute-heat shock causes 
Hsf1 phosphorylation and through the canonical heat shock elements (HSEs) in their 
promoters promote the expression of target heat shock protein (HSP) genes (Nicholls et 
al., 2009). Inductions of cellular adaptation to the heat shock are by refolding or 
degradation of damaged proteins through activation of HSP gene. Following thermal 
adaptation, heat shock protein 90 (HSP90) gene is activated and interacts with Hsf1 to 
repressed the stress response in C. albicans (Leach et al., 2012). Hsp90 is required for 
C. albicans to establish systemic infection. Autoantibodies against Hsp90 gives mild 
protection against the infection (Matthews et al., 1991). 
 
 
 
Heat shock proteins are found on C. albicans cell surface and are immunogenic during 
infections (Lopez-Ribot et al., 1996; Matthews et al., 1987). Induction of heat shock 
proteins by mild thermal insult is associated with yeast-hyphae morphogenesis, which is 
considered to be virulence attribute (Swoboda et al., 1996). A mutant strain with 
mutation that inhibits promotion of the heat shock response in C. albicans has attenuated 
virulence. 
 
 
 
1.6.2 Osmotic and Cationic Stress 
 
 
 
 
Prolonged exposure to salts, such as sodium chloride, NaCl and potassium chloride, KCl 
resulted in dehydration of cells, causing loss of turgor pressure and a reduction in cell 
size due to cationic and osmotic stress (Kuhn & Klipp, 2012). These events will 
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subsequently triggers the expression and phosphorylation of the stress-activated protein 
kinases (SAPK) Hog1 that results in reprogram of the gene expression pattern required 
for cell survival upon osmostress. Examples include regulation of gene encoding 
glycerol biosynthetic enzymes (Enjalbert et al., 2006; Smith et al., 2004). This will 
results in the build-up of glycerol in the cells which will then allow them to balance their 
osmotic pressure with that of surrounding and allowing the resumption of growth. 
Adaptation of C. albicans cells to osmotic/cationic stresses relies on HOG1. It is a major 
regulator of the osmostress-regulated transcription, including activation of glycerol 
biosynthetic gene which will then cause aggregation of glycerol (Smith et al., 2004; San 
Jose et al., 1996). 
 
 
 
Common signaling modules found in both higher and lower eukaryotic cells, such as 
mitogen-activated protein kinase (MAPK) cascades are composed of three succesively 
activated tiers of kinases (MAP kinase kinase kinase, MAP kinase kinase and MAP 
kinase). Hog1 is a component of a highly conserved mitogen-activated protein (MAP) 
kinase pathway. In C. albicans, this MAPK is activated by the MAPKK, Pbs2, which in 
turn is activated by a single MAPKKK, Ssk2 (Arana et al., 2005). The regulators 
network upstream of gene expressions that activate this MAPK module due to exposure 
to osmotic stress in C. albicans is open to interpretation. 
 
 
 
Hog1 (SAPK) regulates both morphogenesis and stress response in C. albicans and is a 
dominant factor for virulence of C. albicans (Cheetham et al., 2011). Adaptation to 
other stresses, such as regulation of cellular morphogenesis and metabolism, oxidative 
stress response, and influence cell wall performance required Hog1 (Alonso-Monge et 
al., 2009; Eisman et al., 2006; Alonso-Monge et al., 2003). Based on several studies, 
18  
adaptation to osmotic and cationic stress are important in host niches, such as in the 
kidney, where the concentrations of NaCl in urine can approach 600 mmol l
−1 
(Z. Zhang 
et al., 2004; Ohno et al., 1997). 
 
 
 
1.6.3 Cell Wall Stress 
 
 
 
 
The fungal cell wall is important for survival and interaction with the surrounding 
environment; it is the point of contact between fungus and target surfaces, and processes 
such as adhesion, dimorphism, and biofilms formation take place. These factors are 
responsible for the pathogenicity of C. albicans. 
 
 
 
Congo Red and Caspofungin are antifungal drug that inhibit and disturb synthesis and 
assembly of β-glucan, whereas Calcofluor White disrupt formation of chitin. These 
antifungal drugs are used to pressure the C. albicans cell wall in vitro (Eisman et al., 
2006; Wiederhold et al., 2005). The Hog1 pathway regulates cell wall stress responses 
and enables the synthesis of chitin (Munro et al., 2007; Eisman et al., 2006). 
 
 
 
Two additional highly conserved MAPK pathways are responsible for regulations of 
stress response in C. albicans cell wall. The first pathway, the Mkc1 facilitated MAPK 
or the cell integrity pathway, and a second pathway, involves in Cek1-mediated MAPK 
or yeast-hypha morphogenesis (Roman et al., 2007). 
 
 
 
Bck1-mediated MAPKKK, Mkk1-mediated MAPKK and Mkc1-mediated MAPK are 
MAPKK module that involves in cell integrity pathway (Navarro-Garcia et al., 1998). 
Cascade of phosphorylation reactions, Mkc1 governed by protein kinase (Pkc1) plays an 
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essential role in the generation of a stable cell wall in yeast (Paravicini et al., 1996). The 
inactivation of Mkc1 increases the cell wall sensitivity to thermal insult and other 
stresses (Navarro-Garcia et al., 1998). Inactivation of Mkc1 does reduce and weaken the 
virulence of C. albicans (Diez-Orejas et al., 1997). However inactivation of this protein 
does not contribute and increase the probability of cell death in response to neutrophils 
or macrophages (Arana et al., 2007). 
 
 
 
MAPKKK Ste11, MAPKK Hst7 and MAPK Cek1 are components of morphogenetic 
MAPK (Cek1) pathway. This pathway also regulate C. albicans mating response and are 
required for efficiency of mating (Chen et al., 2002). Cell surface sensor Msb2 triggers 
Cek1 pathway upon exposure to antifungal agents that target cell wall integrity or 
mutation of gene required for integrity of cell wall (Cantero & Ernst, 2011; Roman et 
al., 2009). Inactivation of Cek1 in C. albicans growing under certain conditions resulted 
in retarded growth of filament and is more prone to cell wall stresses (Eisman et al., 
2006; Csank et al., 1998; Leberer et al., 1996). C. albicans cek1 mutants display 
attenuated virulence but does not affect sensitivity of the cells in response to 
macrophage or neutrophil (Arana et al., 2007; Csank et al., 1998). 
 
 
 
1.6.4 Oxidative Stress 
 
 
 
 
Reactive oxygen species (ROS) is an acting compound causing damage and 
inflammation to the tissue. Resistant to this compound by C. albicans require Cap1, an 
orthologue of AP-1-like transcription factor Yap1 in S. cerevisiae (Alarco & Raymond, 
1999). Following oxidative stress, cysteine residues near the carboxyl terminus Cap1 
which  are  redox-sensitive  was  oxidized  and  subsequently  leads  to  the  nuclear 
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accumulation of Cap1 and Yap1-responsive elements (YRE) in their promoters that will 
activates the target genes. These processes are Hog1 independent (Znaidi et al., 2009; X. 
Zhang et al., 2000). Upon accumulation of Cap1 in C. albicans, genes involved in the 
removal of oxidative stress, such as oxidative damage repair, superoxide dismutase and 
catalase, and redox homeostasis glutathione synthesis was expressed and functions by 
detoxifying ROS and regulates stress adaptation in cells. Deletion of CAP1 will increase 
C. albicans sensitivity to oxidative stress due to decrease promotion of genes and 
enzymes mentioned above (Enjalbert et al., 2006; Alarco & Raymond, 1999). Moreover 
C. albicans mutant strains (cap1/cap1 and hog1/hog/1) display attenuated virulence and 
increased response to phagocytes (Arana et al., 2007; Fradin et al., 2005). 
 
 
 
1.7 Central Metabolism Pathways 
 
 
 
 
In order to proliferate in a broad range of environmental niches, metabolic flexibility 
and virulence factors are important so that they can metabolize different carbon sources 
that are scarce or the only available carbon source at a specific environmental niche. 
Carbohydrates are necessary to produce biomolecules and for generating energy for 
basic functions of cells. Before entering the glycolytic pathway, sugars undergo 
transition to fructose 6-phosphate or glucose 6-phosphate. ATP and NADH are produce 
from the conversion of sugar phosphates into pyruvate in glycolysis pathway. From 
there, fermentation and respiration are carried out by cells. Although NAD+ is 
regenerated by both processes, respiration produces more ATP than fermentation 
through the oxidative phosphorylation and tricarboxylic acid (TCA) cycle. Glycolysis 
pathway is important for carbon metabolism and it is frequently used for both 
fermentation and respiration. This pathway is important to the virulence in pathogenic 
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bacteria, parasites, and fungi, and was up-regulated during infections (Costa et al., 2007; 
Barelle et al., 2006; Rodaki et al., 2006). Glycolysis, gluconeogenesis, and the 
glyoxylate cycle are part of C. albicans central metabolism (Fig. 1.2). 
 
 
 
 
 
 
 
 
Figure 1.2: The pathways of ß-oxidation, the glyoxylate cycle, gluconeogenesis, and 
glycolysis are shown, with the C. albicans gene names (Taken from Lorenz et al., 2004). 
22  
1.7.1 Glycolysis and Gluconeogenesis 
 
 
 
 
Transcript of central metabolic pathway such as glycolysis is strictly regulated in 
response to environmental conditions, such as availability of carbon source, oxygen 
levels, energy needs and metabolite concentrations. Most of the regulators of gene 
expression in glycolytic of other species have not been identified. Understanding of 
transcriptional control of glycolysis in eukaryotes is mainly based on the experimental 
paradigm S. cerevisiae; nonfermentable yeast (Chambers et al., 1995). The transcription 
regulators (Gcr1 and Gcr2) are responsible for inducing the expression of the glycolytic 
genes in S. cerevisiae (Uemura & Fraenkel, 1990; Clifton et al., 1978). Inactivation of 
either gene (GCR1 and GCR2) result in growth defects in response to glucose due to 
unexpressed glycolytic genes (Uemura & Fraenkel, 1990). 
 
 
 
The Crabtree-positive Saccharomyces yeasts is a facultative anaerobes and has glucose 
repression circuit. This is in contrast to that of most other obligate aerobes and 
facultative eukaryotes, which lack the glucose repression circuit. Pyruvate is oxidized to 
carbon dioxide through the TCA cycle in Crabtree-negative organism under aerobic 
conditions. Most aerotolerant organisms are able to metabolize energy anaerobically 
through fermentation pathways to a certain extent to subsequently regenerate NAD+, 
such as Neurospora crassa, Aspergillus oryzae, and Trichoderma reesei. These fungi 
metabolize energy aerobically and the TCA cycle is not affected during growth in 
glucose rich which is different in S. cerevisiae that rely heavily on fermentation pathway 
(Maeda et al., 2004; X. Xie et al., 2004; Chambergo et al., 2002). 
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C. albicans is an opportunistic fungus that is capable of metabolizing carbon sources 
through respiration and fermentation pathway. C. albicans is a Crabtree-negative 
organism  that  does  not  have GCR1/2 homologs  and  it  regulates  transcription  of 
glycolytic genes in different way compared to S. cerevisiae. Tye7 and Gal4 activates the 
glycolytic pathway in C. albicans and severe growth defects was observed in the mutant 
strains (tye7 and gal4) cultured on a certain condition. C. albicans mutant strains (tye7 
and gal4) showed attenuated virulence in Galleria mellonella infection model. Therefore 
TYE7 and GAL4 genes are required for pathogenicity and virulence of C. albicans 
(Askew et al., 2009). 
 
 
 
Gluconeogenesis is required for yeast cells to generate sugar phosphates for the 
synthesis of essential cellular components, during growth on non-fermentable carbon 
sources. During growth on unbalanced carbon sources, S. cerevisiae and C. albicans 
shunt glycolysis pathway, this is achieved by enzymes of gluconeogenesis, such as 
phosphoenolpyruvate carboxykinase, and fructose-1,6-bisphosphatase. The enzymes of 
the glyoxylate cycle are necessary for gluconeogenesis, such as malate synthase (MLS) 
and isocitrate lyase (ICL). 
 
 
 
1.7.2 The Tricarboxylate Acid (TCA) and Glyoxylate Cycle 
 
 
 
 
The glyoxylate cycle is also known as a “modified tricarboxylic acid (TCA) cycle”. 
Isocitrate lyase, ICL1 and malate synthase, MLS1 are enzymes in glyoxylate cycle that 
functions by converting isocitrate and acetyl-CoA into succinate and malate respectively 
(Fig 1.2). In glyoxylate cycle, isocitrate was metabolized into succinate and glyoxylate 
which are subsequently condensed by malate synthase, MLS1 and accompanied by 
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acetyl-CoA to produce free CoA-SH and malate. Consequently malate is further 
processed by malate dehydrogenase and produce succinate as a final product. Succinate 
can be reused in the TCA cycle or to operate as carbohydrate biosynthesis indicator or 
biosynthesis of amino acid. Fatty acids or C2-units such as ethanol or acetate are utilized 
by glyoxylate cycle to produce succinate, a C4-units carbon sources through various 
catabolic processes. Succinate is then metabolize by glyoxylate cycle to produce energy 
(Kornberg & Madsen, 1958). In contrast, carbon sources such as ethanol, acetate or oleic 
acid cannot be metabolized by S. cerevisiae because it has deficiency in Icl1 or Mls1. 
Moreover growth on these carbon sources greatly repress the expression of gene 
involved in metabolism of nitrogen, malate synthase (DAL7) (Kunze et al., 2002; 
Fernandez et al., 1992; Hartig et al., 1992). In recent year, key enzyme such as isocitrate 
lyase in glyoxylate cycle is greatly studied. Mutant strain (icl/icl) has attenuated 
virulence in mouse model (Lorenz & Fink, 2001). This provide a platform for anti- 
fungal testing to reduce the virulency of C. albicans 
 
 
 
1.8 Glucose Sensing 
 
 
 
 
In the presence of glucose, C. albicans undergoes yeast-to-hyphal transition which is 
crucial for virulence and invasion of host cells (Hudson et al., 2004), as explained 
previously (Section 1.4.3) morphological plasticity is important factor for C. albicans 
virulency. The hyphal form can diffused through the tissues or form mycelial biofilms, 
and the yeast form is presume to be able to propogate easily via body fluids (Bendel et 
al., 2003). 
